Thorne HealthTech, Inc. (NASDAQ:THRN) Q4 2022 Earnings Call Transcript

Steven Mah: Okay. Thanks. And then about the BD timings of OneDraw?

Paul Jacobson: Yes. So I would see that we hope to be able to put something into the public forum by the middle of the year.

Steven Mah: Okay. Great. And then similarly, on the microbiome wipe, could you give us any business development updates there for choose by others as a medical device?

Unidentified Company Representative: We’re exploring the possibility to register the microbiome wipes in partnership with a medical device company. As we mentioned before, we have our core business focus on consumer, and we’re not a medical device company. So we do not have a plan to register the device ourselves, but we’re actually doing these developments in the United States. Meanwhile, also for the opportunity for international, especially in focus on Asia.

Paul Jacobson: Yes, some of the people in Asia that have had an interest in the OneDraw device are similarly doing the same thing in the microbiome wipe.

Steven Mah: Okay. Great. Thanks €“ the color on that. And then maybe if I could sneak one last in. Could you provide any color on the brain health, timing of launch? Thank you.

Paul Jacobson: Yes. Go ahead, Michelle, because you’re working on the marketing side.

Michelle Crow: Yes. So as it relates to the brain health launch, we’re beginning our pilot beta testing right now to really trying to identify the exact target market and finalize our testing profile, and we are hoping to launch by Q4.

Paul Jacobson: Also, Steven, I’ve mentioned that a big part of this platform includes product development and through our bioinformatics platform. And I mentioned in the prepared remarks, SynaQuell. And we are going to update everyone very soon on some of the clinical trial results coming out of the Mayo Clinic trial, which was run on concussed hockey players during the course of the season.

Steven Mah: Okay, great. Thank you.

Operator: Thank you. At this stage, we currently have no further questions, and therefore, this concludes the Q&A session and today’s call. Thank you so much for joining. You may now disconnect your lines.